Lipocine
LPCN
#10348
Rank
HK$0.14 B
Marketcap
HK$17.31
Share price
-2.21%
Change (1 day)
-39.03%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: HK$0.14 Billion

As of May 2026 Lipocine has a market cap of HK$0.14 Billion. This makes Lipocine the world's 10348th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.14 B-36.83%
2025HK$0.22 B14.32%
2024HK$0.19 B70.62%
2023HK$0.11 B-57.89%
2022HK$0.27 B-59.68%
2021HK$0.68 B-1.47%
2020HK$0.69 B513.62%
2019HK$0.11 B-48.99%
2018HK$0.22 B-61.17%
2017HK$0.56 B9.32%
2016HK$0.52 B-71.5%
2015HK$1.82 B250.27%
2014HK$0.52 B-35.59%
2013HK$0.81 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of Lipocine was reported to be:

HK$0.14 Billion
by Nasdaq info icon info icon
HK$0.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
HK$338.01 B 236,756.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$112.80 B 78,949.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
HK$81.66 M-42.78%๐Ÿ‡บ๐Ÿ‡ธ USA